Hua HY - Search Results

1

Prognostic significance of serum aspartic transaminase in diffuse large B-cell lymphoma.

Lu TX, Wu S, Cai DY, Hong TT, Zhang Y, Gao HQ, Hua HY, Wu XH. Lu TX, et al. Among authors: hua hy. BMC Cancer. 2019 Jun 8;19(1):553. doi: 10.1186/s12885-019-5758-2. BMC Cancer. 2019. PMID: 31176361 Free PMC article.

2

Arsenic trioxide and triptolide synergistically induce apoptosis in the SKM‑1 human myelodysplastic syndrome cell line.

Hua HY, Gao HQ, Sun AN, Cen JN, Wu LL. Hua HY, et al. Mol Med Rep. 2016 Nov;14(5):4180-4186. doi: 10.3892/mmr.2016.5779. Epub 2016 Sep 26. Mol Med Rep. 2016. PMID: 27665715 Free PMC article.

3

Inflammation marker ESR is effective in predicting outcome of diffuse large B-cell lymphoma.

Wu S, Zhou Y, Hua HY, Zhang Y, Zhu WY, Wang ZQ, Li J, Gao HQ, Wu XH, Lu TX, Hua D. Wu S, et al. Among authors: hua hy, hua d. BMC Cancer. 2018 Oct 19;18(1):997. doi: 10.1186/s12885-018-4914-4. BMC Cancer. 2018. PMID: 30340560 Free PMC article.

4

CD5⁺MYC⁺ predicts worse prognosis in diffuse large B-cell lymphoma.

Lu TX, Wu S, Zhou XY, Zhang Y, Hong TT, Cai DY, Hua HY, Qi XW, Wu XH. Lu TX, et al. Among authors: hua hy. Exp Mol Pathol. 2020 Feb;112:104326. doi: 10.1016/j.yexmp.2019.104326. Epub 2019 Nov 9. Exp Mol Pathol. 2020. PMID: 31706988

5

Clinical effectiveness of matrine sitz bath in treating perianal infection after chemotherapy for acute leukemia.

Zhou Y, Gao H, Hua H, Zhu W, Wang Z, Zhang Y, Wu S, Li J, Zhao Y, Xue L. Zhou Y, et al. Ann Palliat Med. 2020 May;9(3):1109-1116. doi: 10.21037/apm-20-912. Ann Palliat Med. 2020. PMID: 32498526 Free article. Clinical Trial.

6

[Curative Efficacy and Survival Analysis of Low-Intensity Traditional Chemotherapy Regimen in the Elderly Patients with Acute Myeloid Leukemia (non-M₃)].

Wang ZQ, Dai XB, Hua HY, Gao HQ, Zhu WY, Zhou Y, Zhang Y, Wu S, Li J, Zhao Y, Xu ZQ, Zhu XJ, Sun XM. Wang ZQ, et al. Among authors: hua hy. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2020 Oct;28(5):1516-1522. doi: 10.19746/j.cnki.issn.1009-2137.2020.05.015. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2020. PMID: 33067947 Chinese.

7

A Novel and Validated Inflammation-Based Prognosis Score (IBPS) Predicts Outcomes in Patients with Diffuse Large B-Cell Lymphoma.

Liu Y, Sheng L, Hua H, Zhou J, Zhao Y, Wang B. Liu Y, et al. Cancer Manag Res. 2023 Jul 13;15:651-666. doi: 10.2147/CMAR.S408100. eCollection 2023. Cancer Manag Res. 2023. PMID: 37465083 Free PMC article.

8

An Externally Validated Nomogram for Predicting the Overall Survival of Patients With Diffuse Large B-Cell Lymphoma Based on Clinical Characteristics and Systemic Inflammatory Markers.

Liu Y, Sheng L, Hua H, Zhou J, Zhao Y, Wang B. Liu Y, et al. Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338231180785. doi: 10.1177/15330338231180785. Technol Cancer Res Treat. 2023. PMID: 37551117 Free PMC article.

9

Low NDRG2, regulated by the MYC/MIZ-1 complex and methylation, predicts poor outcomes in DLBCL patients.

Wu S, Zhang J, Chen S, Zhou X, Liu Y, Hua H, Qi X, Mao Y, Young KH, Lu T. Wu S, et al. Ann Hematol. 2024 Aug;103(8):2877-2892. doi: 10.1007/s00277-024-05829-2. Epub 2024 Jun 6. Ann Hematol. 2024. PMID: 38842567

10

[Systemic Inflammatory Markers Can Improve Survival Prediction of Patients with Diffuse Large B-Cell Lymphoma: Model Development and Evaluation].

Liu YJ, Sheng L, Zhou JF, Hua HY. Liu YJ, et al. Among authors: hua hy. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2024 Aug;32(4):1136-1145. doi: 10.19746/j.cnki.issn.1009-2137.2024.04.025. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2024. PMID: 39192410 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

67 results

Search Page

Filters